AUY922, a novel HSP90 inhibitor: Final results of a First-in-human study in patients with advanced solid malignancies.

被引：23
|
作者：
Samuel, T. A.
Sessa, C.
Britten, C.
Milligan, K. S.
Mita, M. M.
Banerji, U.
Pluard, T. J.
Stiegler, P.
Quad, C.
Shapiro, G.
机构：
[1] Med Coll Georgia, Augusta, GA 30912 USA
[2] Osped Reg Bellinzona & Valli, Oncol Inst Southern Switzerland, Bellinzona, Switzerland
[3] Univ Calif Los Angeles, Clin Res Unit, Los Angeles, CA USA
[4] Nevada Canc Inst, Las Vegas, NV USA
[5] Canc Therapy & Res Ctr S Texas, San Antonio, TX 78229 USA
[6] Royal Marsden Hosp, Drug Dev Unit, Sutton, Surrey, England
[7] Washington Univ, Sch Med, Div Med Oncol, St Louis, MO USA
[8] Novartis Pharmaceut, E Hanover, NJ USA
[9] Novartis Pharmaceut, Basel, Switzerland
[10] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.2528
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2528
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Novel Hsp90 inhibitor NVP-AUY922 sensitizes human tumor xenografts to radiation
    Kuger, S.
    Elsner, I
    Katzer, A.
    Flentje, M.
    Djuzenova, C. S.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 117 - 117
  • [22] Potent antitumor activity of the novel HSP90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells
    Zitzmann, Kathrin
    Ailer, Galina
    Vlotides, George
    Spoettl, Gerald
    Maurer, Julian
    Goeke, Burkhard
    Beuschlein, Felix
    Auernhammer, Christoph J.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 43 (06) : 1824 - 1832
  • [23] Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma
    Augello, Giuseppa
    Emma, Maria Rita
    Cusimano, Antonella
    Azzolina, Antonina
    Mongiovi, Sarah
    Puleio, Roberto
    Cassata, Giovanni
    Gulino, Alessandro
    Belmonte, Beatrice
    Gramignoli, Roberto
    Strom, Stephen C.
    McCubrey, James A.
    Montalto, Giuseppe
    Cervello, Melchiorre
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (10) : 2613 - 2624
  • [24] Reactivation of ERK and Akt confers resistance of mutant BRAF colon cancer cells to the HSP90 inhibitor AUY922
    Wang, Chun Yan
    Guo, Su Tang
    Wang, Jia Yu
    Yan, Xu Guang
    Farrelly, Margaret
    Zhang, Yuan Yuan
    Liu, Fen
    Yari, Hamed
    La, Ting
    Lei, Fu Xi
    Jin, Lei
    Zhang, Xu Dong
    Jiang, Chen Chen
    ONCOTARGET, 2016, 7 (31) : 49597 - 49610
  • [25] Novel Hsp90 Inhibitor NVP-AUY922 Radiosensitizes Prostate Cancer Cells
    Gandhi, N.
    Wild, A. T.
    Aziz, K.
    Chettiar, S.
    Gajula, R.
    Zeng, J.
    Herman, J.
    Deweese, T. L.
    Hales, R.
    Tran, P. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S178 - S178
  • [26] Radiosensitizing effect of the novel Hsp90 inhibitor NVP-AUY922 in human tumour cell lines silenced for Hsp90αRadiosensibilisierender Effekt des neuartigen Hsp90-Inhibitors NVP-AUY922 in Hsp90α-inhibierten humanen Tumorzelllinien
    L. Stingl
    N. Niewidok
    N. Müller
    M. Selle
    C.S. Djuzenova
    M. Flentje
    Strahlentherapie und Onkologie, 2012, 188 (6) : 507 - 517
  • [27] REACTIVATION OF ERK AND AKT CONFERS RESISTANCE OF MUTANT BRAF COLON CANCER CELLS TO THE HSP90 INHIBITOR AUY922
    Wang, Chun Yan
    Guo, Su Tang
    Wang, Jia Yu
    Yan, Xu Guang
    Farrelly, Margaret
    Zhang, Yuan Yuan
    Liu, Fen
    Yari, Hamed
    La, Ting
    Lei, Fu Xi
    Jin, Lei
    Zhang, Xu Dong
    Jiang, Chen Chen
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 33 - 33
  • [28] PHASE II ACTIVITY OF THE HSP90 INHIBITOR AUY922 IN PATIENTS WITH EGFR-MUTANT ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC
    Barlesi, Fabrice
    Besse, Benjamin
    Chu, Quincy
    Gandhi, Leena
    Griesinger, Frank
    Felip, Enriqueta
    Kang, Jin Hyoung
    Kim, Sang-We
    Rosell, Rafael
    Sequist, Lecia V.
    Soo, Ross
    Wallmark, John
    Avsar, Emin
    Ofosu-Appiah, William
    Pain, Scott
    Akimov, Mikhail
    Garon, Edward B.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S611 - S612
  • [29] Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells
    Gandhi, Nishant
    Wild, Aaron T.
    Chettiar, Sivarajan T.
    Aziz, Khaled
    Kato, Yoshinori
    Gajula, Rajendra P.
    Williams, Russell D.
    Cades, Jessica A.
    Annadanam, Anvesh
    Song, Danny
    Zhang, Yonggang
    Hales, Russell K.
    Herman, Joseph M.
    Armour, Elwood
    DeWeese, Theodore L.
    Schaeffer, Edward M.
    Tran, Phuoc T.
    CANCER BIOLOGY & THERAPY, 2013, 14 (04) : 347 - 356
  • [30] PHARMACODYNAMIC EFFECTS OF THE HEAT SHOCK PROTEIN 90 (HSP90) INHIBITOR, AUY922, IN HIGH-RISK, LOCALISED PROSTATE CANCER
    Zhang, A. Y.
    Butler, L. M.
    Stricker, P. D.
    Kench, J. G.
    Tilley, W. D.
    Sebastian, L.
    Stockler, M.
    Horvath, L.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 46 - 46
12345